Literature DB >> 8641203

Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat.

H F Escobar-Morreale1, F E del Rey, M J Obregón, G M de Escobar.   

Abstract

We have recently shown that it is not possible to restore euthyroidism completely in all tissues of thyroidectomized rats infused with T4 alone. The present study was undertaken to determine whether this is achieved when T3 is added to the continuous sc infusion of T4. Thyroidectomized rats were infused with placebo or T4 (0.80 and 0.90 microgram/100 g BW.day), alone or in combination with T3 (0.10, 0.15, or 0.20 microgram/100 g BW.day). Placebo-infused intact rats served as euthyroid controls. Plasma and 12 tissues were obtained after 12 days of infusion. Plasma TSH and plasma and tissue T4 and T3 were determined by RIA. Iodothyronine deiodinase activities were assayed using cerebral cortex, pituitary, brown adipose tissue, liver, and lung. Circulating and tissue T4 levels were normal in all the groups infused with thyroid hormones. On the contrary, T3 in plasma and most tissues and plasma TSH only reached normal levels when T3 was added to the T4 infusion. The combination of 0.9 microgram T4 and 0.15 microgram T3/100 g BW.day resulted in normal T4 and T3 concentrations in plasma and all tissues as well as normal circulating TSH and normal or near-normal 5'-deiodinase activities. Combined replacement therapy with T4 and T3 (in proportions similar to those secreted by the normal rat thyroid) completely restored euthyroidism in thyroidectomized rats at much lower doses of T4 than those needed to normalize T3 in most tissues when T4 alone was used. If pertinent to man, these results might well justify a change in the current therapy for hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641203     DOI: 10.1210/endo.137.6.8641203

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  62 in total

1.  Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase.

Authors:  V A Galton; E Martinez; A Hernandez; E A St Germain; J M Bates; D L St Germain
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.

Authors:  Francesco S Celi; Marina Zemskova; Joyce D Linderman; Nabeel I Babar; Monica C Skarulis; Gyorgy Csako; Robert Wesley; Rene Costello; Scott R Penzak; Frank Pucino
Journal:  Clin Endocrinol (Oxf)       Date:  2010-05       Impact factor: 3.478

Review 3.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

4.  Effects of experimental increases and decreases in thyroxine levels on the extent of cataleptic freezing reactions in rats.

Authors:  A V Kulikov; M A Tikhonova; E I Lebedeva; V F Chugui; N K Popova
Journal:  Neurosci Behav Physiol       Date:  2005-09

5.  Comparative bioavailability of different formulations of levothyroxine and liothyronine in healthy volunteers.

Authors:  G M Leggio; T Incognito; G Privitera; M R Marano; F Drago
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

6.  Thyroid hormone-induced alterations in membrane structure-function relationships: studies on kinetic properties of rat kidney microsomal Na(+),K (+)-ATPase and lipid/phospholipid profiles.

Authors:  Surendra S Katyare; Hiren R Modi; Samir P Patel; Minal A Patel
Journal:  J Membr Biol       Date:  2007-08-28       Impact factor: 1.843

7.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 8.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

9.  The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy.

Authors:  Sahzene Yavuz; Joyce D Linderman; Sheila Smith; Xiongce Zhao; Frank Pucino; Francesco S Celi
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

10.  Hypothyroidism enhances tumor invasiveness and metastasis development.

Authors:  Olaia Martínez-Iglesias; Susana García-Silva; Javier Regadera; Ana Aranda
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.